Literature DB >> 7917518

Genetic analysis of HIV-1 isolates from Brazil reveals presence of two distinct genetic subtypes.

J Louwagie1, E L Delwart, J I Mullins, F E McCutchan, G Eddy, D S Burke.   

Abstract

The spread of the human immunodeficiency virus type 1 (HIV-1) is by now virtually worldwide. An understanding of the genetic, biological, and immunological differences among isolates collected in different geographic locales is crucial for the development of globally effective vaccines. Here we report the genetic characteristics of 21 HIV-1 isolates from Brazil. The isolates were initially characterized using a heteroduplex mobility assay. The majority (17 of 21) were related to North American/European reference isolates of genetic subtype B. Four isolates belonged to a more recently identified genotype, termed subtype F. The subtype F sequences from Brazil are distinguishable in both gag and env from five other genetic subtypes of HIV-1 currently recognized. Like many locales, Brazil harbors more than one HIV-1 subtype.

Entities:  

Keywords:  Acquired Immunodeficiency Syndrome; Americas; Antigens; Biology; Brazil; Developing Countries; Diseases; Examinations And Diagnoses; Genetics; Hiv; Hiv Infections; Hiv Serodiagnosis; Immunity; Immunologic Factors; Laboratory Examinations And Diagnoses; Laboratory Procedures; Latin America; Physiology; South America; Viral Diseases

Mesh:

Substances:

Year:  1994        PMID: 7917518     DOI: 10.1089/aid.1994.10.561

Source DB:  PubMed          Journal:  AIDS Res Hum Retroviruses        ISSN: 0889-2229            Impact factor:   2.205


  28 in total

1.  Identification of a novel HIV-1 inhibitor targeting Vif-dependent degradation of human APOBEC3G protein.

Authors:  Erez Pery; Ann Sheehy; N Miranda Nebane; Andrew Jay Brazier; Vikas Misra; Kottampatty S Rajendran; Sara J Buhrlage; Marie K Mankowski; Lynn Rasmussen; E Lucile White; Roger G Ptak; Dana Gabuzda
Journal:  J Biol Chem       Date:  2015-02-27       Impact factor: 5.157

2.  Identification of single and dual infections with distinct subtypes of human immunodeficiency virus type 1 by using restriction fragment length polymorphism analysis.

Authors:  L M Janini; D Pieniazek; J M Peralta; M Schechter; A Tanuri; A C Vicente; N dela Torre; N J Pieniazek; C C Luo; M L Kalish; G Schochetman; M A Rayfield
Journal:  Virus Genes       Date:  1996       Impact factor: 2.332

3.  The Honduran human immunodeficiency virus type 1 (HIV-1) epidemic is dominated by HIV-1 subtype B as determined by V3 domain sero- and genotyping.

Authors:  C Lara; M Sällberg; B Johansson; I L de Rivera; A Sönnerborg
Journal:  J Clin Microbiol       Date:  1997-03       Impact factor: 5.948

Review 4.  Recurrent CDC group IVc-2 bacteremia in a human with AIDS.

Authors:  R R Anderson; P Warnick; P C Schreckenberger
Journal:  J Clin Microbiol       Date:  1997-03       Impact factor: 5.948

5.  Exploration of antigenic variation in gp120 from clades A through F of human immunodeficiency virus type 1 by using monoclonal antibodies.

Authors:  J P Moore; F E McCutchan; S W Poon; J Mascola; J Liu; Y Cao; D D Ho
Journal:  J Virol       Date:  1994-12       Impact factor: 5.103

6.  Infectious molecular clones with the nonhomologous dimer initiation sequences found in different subtypes of human immunodeficiency virus type 1 can recombine and initiate a spreading infection in vitro.

Authors:  D C St Louis; D Gotte; E Sanders-Buell; D W Ritchey; M O Salminen; J K Carr; F E McCutchan
Journal:  J Virol       Date:  1998-05       Impact factor: 5.103

7.  Improved guanide compounds which bind the CXCR4 co-receptor and inhibit HIV-1 infection.

Authors:  Royce A Wilkinson; Seth H Pincus; Kejing Song; Joyce B Shepard; Alan J Weaver; Mohamed E Labib; Martin Teintze
Journal:  Bioorg Med Chem Lett       Date:  2013-01-30       Impact factor: 2.823

8.  Diversity of HIV-1 subtype B: implications to the origin of BF recombinants.

Authors:  Elcio Leal; Fabiola E Villanova
Journal:  PLoS One       Date:  2010-07-28       Impact factor: 3.240

9.  Cross-clade neutralization of primary isolates of human immunodeficiency virus type 1 by human monoclonal antibodies and tetrameric CD4-IgG.

Authors:  A Trkola; A B Pomales; H Yuan; B Korber; P J Maddon; G P Allaway; H Katinger; C F Barbas; D R Burton; D D Ho
Journal:  J Virol       Date:  1995-11       Impact factor: 5.103

10.  Serologic evaluation of human immunodeficiency virus type 1-infected individuals from Argentina and the United States indicates a similar distribution of subgroup B isolates.

Authors:  R Q Warren; M T Wong; G P Melcher; S P Blatt; P Cahn; H Perez; I Zapiola; M B Bouzas; G Muchinik; S A Anderson
Journal:  J Clin Microbiol       Date:  1995-02       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.